Novartis in trouble in India

Talk about being stuck between a rock and a hard place; but what is Novartis supposed to do about its current problems over patents relating to its cancer treatment Glivec (Gleevec) in India? As the company must have expected, it is now facing a…

Get unlimited access to all IAM content